DMK
David M. Knott Portfolio holdings
AUM
$264M
This Quarter Return
+22.93%
1 Year Return
+57.14%
3 Year Return
+78.48%
5 Year Return
+218.77%
10 Year Return
–
AUM
$221M
AUM Growth
+$221M
(+30%)
Cap. Flow
+$21.3M
Cap. Flow
% of AUM
9.65%
Top 10 Holdings %
Top 10 Hldgs %
55.64%
Holding
118
New
18
Increased
17
Reduced
14
Closed
8
Top Buys
| 1 |
DNMR
Danimer Scientific, Inc.
DNMR
|
$11.8M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
$3.36M |
| 3 |
Eastern Bankshares
EBC
|
$3.26M |
| 4 |
MDWT
Midwest Holding Inc. Common Stock
MDWT
|
$3.23M |
| 5 |
Gilead Sciences
GILD
|
$3.14M |
Top Sells
| 1 |
SRCL
Stericycle Inc
SRCL
|
$10.1M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$1.33M |
| 3 |
LKQ Corp
LKQ
|
$1.06M |
| 4 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$781K |
| 5 |
Pfizer
PFE
|
$704K |
Sector Composition
| 1 | Healthcare | 34.97% |
| 2 | Financials | 19.59% |
| 3 | Materials | 10% |
| 4 | Technology | 8.95% |
| 5 | Industrials | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
DigitalBridge
DBRG
$2.05B
| $7K | ﹤0.01% |
1,466
| – | – |
|
102
Viatris
VTRS
$12.3B
| $5K | ﹤0.01% |
+80
| New | +$5K |
|
|
SCU
103
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $3K | ﹤0.01% |
200
| – | – |
|
104
Alerian MLP ETF
AMLP
$10.6B
| $3K | ﹤0.01% |
120
| – | – |
|
105
Check-Cap
CHEK
$3.95M
| $1K | ﹤0.01% |
2,224
| – | – |
|
106
The RMR Group
RMR
$279M
| $1K | ﹤0.01% |
16
| – | – |
|
107
Wabtec
WAB
$32.7B
| $1K | ﹤0.01% |
23
| – | – |
|
|
SBBP
108
DELISTED
Strongbridge Biopharma plc.
SBBP
| – | – |
-372,000
| Closed | -$781K |
|
|
CCXI
109
DELISTED
ChemoCentryx, Inc.
CCXI
| – | – |
-6,587
| Closed | -$361K |
|
|
SRCL
110
DELISTED
Stericycle Inc
SRCL
| – | – |
-160,000
| Closed | -$10.1M |
|
111
Alkermes
ALKS
$4.95B
| – | – |
-38,000
| Closed | -$630K |
|
112
Collegium Pharmaceutical
COLL
$1.25B
| – | – |
-29,862
| Closed | -$622K |
|
113
Cardiff Oncology
CRDF
$130M
| – | – |
-5,000
| Closed | -$71K |
|
114
Cytokinetics
CYTK
$5.98B
| – | – |
-15,837
| Closed | -$343K |
|
115
Krystal Biotech
KRYS
$4.35B
| – | – |
-7,079
| Closed | -$305K |
|